A sold-out summit at the London Institute for Healthcare Engineering will bring together innovators, clinicians, regulators, investors and policymakers to explore how artificial intelligence can address some of the biggest challenges in women's health, while ensuring innovation is developed responsibly and equitably.
With AI capability advancing at pace, the technology is increasingly being applied to women's healthcare, offering the potential for earlier diagnosis, improved risk prediction and more personalised care. The summit will showcase pioneering innovations designed to tackle clinical challenges in women's health and examine how the sector can ensure women are not left behind in the next wave of healthcare transformation.
AI × Women's Health: Innovation, Challenges and Opportunities, taking place on 25 June, is organised by femtech company MEGI Health, which is developing an innovative digital cardiovascular platform designed to support lifelong cardiovascular care for women, starting with pregnancy and extending through postpartum care and beyond. All 140 places have been taken, with a waiting list in operation.
The summit lands at an energising moment for the field. Women's health is starting to attract serious investment, policy attention and ambitious founders, and AI is moving from research into real clinical use at increasing pace. According to the World Economic Forum and the McKinsey Health Institute, closing the women's health gap could add at least $1 trillion to the global economy a year by 2040. The day will spotlight tools addressing clinical challenges being built and deployed, spanning fetal and gynaecological ultrasound, maternal cardiovascular monitoring and AI-supported clinical decision-making.
Alongside the innovation, the summit is designed to convene discussions about opportunities and challenges. AI is only as good as the data behind it, and women have long been under-represented in medical research and health data, which means tools built on incomplete or unrepresentative data risk carrying those gaps forward. The programme tackles data gaps, ethics, privacy and equity directly, with clinicians, regulators and funders in the room together.
Dr Fran Conti-Ramsden, clinician at Guy's and St Thomas' NHS Foundation Trust, academic at King's College London and Chief Medical Officer of MEGI Health, said: “Working at the intersection of clinical practice, academia and industry, I see both the tremendous challenges we face in delivering clinical care for women and the need for innovation, alongside the rapid development of AI and digital health technologies. But bringing innovation into clinical practice is fraught with challenges. I hope this day brings together people from across the landscape to discuss and define those challenges as well as celebrate progress in the field, sparking dialogue on how we should innovate responsibly, and to make sure women's health is not left behind.”
Nina Sesto, CEO of MEGI Health, said: “We are seeing a wave of innovation in women's health, and AI has the potential to accelerate it. The opportunity is enormous, but it only pays off if these tools are built on representative data and designed around the realities of women's health. That is exactly the conversation we wanted to convene, across clinicians, researchers, industry and regulators.”
The half-day programme runs across four sessions. An opening session chaired by Professor Eugene Oteng-Ntim sets the historical, ethical and equity context. A second, chaired by Professor Richard Dobson, looks at how clinicians and researchers are putting AI to work on real clinical challenges and getting it adopted safely in the NHS. An interactive session offers a practical primer on what AI can today alongside pitfalls, with small-group breakouts. A closing session chaired by Professor Asma Khalil brings founders into conversation with regulators and investors on the realities of building, funding and scaling AI tools in women's health.
Speakers and chairs include Professor Eugene Oteng-Ntim (Guy’s and St Thomas’ NHS FT), Professor Asma Khalil (St George’s Hospital), Professor Richard Dobson (King’s College London), MiRa Jacobs (MHRA), Professor Jane Hirst (The George Institute), Nell Thornton (The Health Foundation), Dr Alex Deng (Director NHS Fellowship in Clinical AI), Elsa Zekeng (Soker Data), Dr Bianca Schor (Amsterdam UMC), Tulsi Patel (Hertility), Jackie Matthews (FRAIYA), Dr Katy Kuhrt (King's College London), Dika Vilić (Guy's and St Thomas'), Dr Kimberley Peven (Scarlet), Ruba Abu-Salma (King’s College London), Steph Jones (AI Centre for Value Based Healthcare) and Esther Richardot Reynal de Saint-Michel (Thena Capital).
Organisers hope the day will help seed a lasting UK community around clinical AI in women's health, aligning fast-moving innovation with clinical need so that women benefit from the next wave of healthcare technology.
AI × Women's Health: Innovation, Challenges and Opportunities takes place on Thursday 25 June 2026 at the London Institute for Healthcare Engineering, 100 Lambeth Palace Road, London SE1 7AR. The event is free, fully booked, and operating a waiting list: https://www.eventbrite.co.uk/e/ai-womens-health-innovation-challenges-and-opportunities-tickets-1990283050180?aff=oddtdtcreator
